CH504452A - Verfahren zur Herstellung von Morpholinderivaten - Google Patents

Verfahren zur Herstellung von Morpholinderivaten

Info

Publication number
CH504452A
CH504452A CH1697067A CH1697067A CH504452A CH 504452 A CH504452 A CH 504452A CH 1697067 A CH1697067 A CH 1697067A CH 1697067 A CH1697067 A CH 1697067A CH 504452 A CH504452 A CH 504452A
Authority
CH
Switzerland
Prior art keywords
preparation
morpholine derivatives
morpholine
derivatives
Prior art date
Application number
CH1697067A
Other languages
English (en)
Inventor
Blakeney Mallion Keith
William Turner Ralph
Henry Todd Alexander
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Priority to CH506670A priority Critical patent/CH505849A/de
Priority to CH1707670A priority patent/CH531528A/de
Publication of CH504452A publication Critical patent/CH504452A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1697067A 1966-12-28 1967-12-01 Verfahren zur Herstellung von Morpholinderivaten CH504452A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH506670A CH505849A (de) 1966-12-28 1967-12-01 Verfahren zur Herstellung von Morpholinderivaten
CH1707670A CH531528A (de) 1967-12-01 1970-11-17 Verfahren zur Herstellung von neuen Morpholinderivaten und deren Säureadditionssalzen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB57963/66A GB1138405A (en) 1966-12-28 1966-12-28 Morpholine derivatives
GB5796367 1966-12-28

Publications (1)

Publication Number Publication Date
CH504452A true CH504452A (de) 1971-03-15

Family

ID=26267707

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1697067A CH504452A (de) 1966-12-28 1967-12-01 Verfahren zur Herstellung von Morpholinderivaten

Country Status (7)

Country Link
US (1) US3714161A (de)
BE (1) BE708557A (de)
CH (1) CH504452A (de)
DE (1) DE1695295C2 (de)
FR (2) FR1571341A (de)
GB (1) GB1138405A (de)
NL (1) NL157303B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959273A (en) * 1966-12-28 1976-05-25 Imperial Chemical Industries Limited Morpholine derivatives
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
BE759013R (fr) * 1969-11-17 1971-05-17 Ici Ltd Derives de la
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la
US3806595A (en) * 1971-08-09 1974-04-23 Ici Ltd Method of producing anorexia
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
US4033951A (en) * 1973-12-13 1977-07-05 Imperial Chemical Industries Limited Morpholine derivative of a 1,4-benzothiazin-3-one
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
CA1064927A (en) * 1975-01-29 1979-10-23 Yuji Kawashima Process of producing 2-(indenyloxymethyl) morpholine derivatives
US4109088A (en) * 1975-01-29 1978-08-22 Yamanouchi Pharmaceutical Co., Ltd. 2-(indenyloxymethyl) morpholine derivatives
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
DE2530860C2 (de) * 1975-07-10 1987-01-15 Yoshitomi Pharmaceutical Industries, Ltd., Osaka 2-[2-(2-Thenyl)-phenoxymethyl]-morpholin-Derivate
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4241059A (en) * 1979-12-17 1980-12-23 E. R. Squibb & Sons, Inc. 6-[(Aryloxy)methyl]-2-morpholinemethanol derivatives and use thereof
FR2534915B1 (fr) * 1982-10-26 1985-10-25 Lafon Labor Nouveaux derives de 2-(phenoxymethyl)-morpholine, utilisation en therapeutique et procede de preparation
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2612926B1 (fr) * 1987-03-24 1989-06-09 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant
EP0629190A1 (de) * 1992-01-28 1994-12-21 Smithkline Beecham Plc Verbindungen als calcium kanal antagoniste
CA2155183A1 (en) * 1993-02-10 1994-08-18 Mitsuo Fujii Morpholine derivative
AU9087301A (en) 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
AP2006003771A0 (en) * 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
SI2076508T1 (sl) 2006-10-18 2011-04-29 Pfizer Prod Inc Spojine biaril eter sečnine
CA2735934C (en) 2008-09-05 2014-01-07 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (adhd)
EP2558437B1 (de) 2010-04-12 2015-08-05 Supernus Pharmaceuticals, Inc. Verfahren zur herstellung von viloxazinsalzen und neue polymorphe daraus
WO2011146821A2 (en) 2010-05-21 2011-11-24 Research Triangle Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
EP4317141A1 (de) 2022-08-04 2024-02-07 Curia Spain S.A.U. Verfahren und zwischenprodukte zum herstellen von vioxazin und anderen 2-substituierten morpholinderivaten
WO2025219523A1 (en) 2024-04-19 2025-10-23 Cambrex Profarmaco Milano S.R.L. "intermediates and processes for the preparation of viloxazine"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH356451A (de) * 1957-04-05 1961-08-31 Geigy Ag J R Verfahren zur Herstellung von neuen Morpholinverbindungen

Also Published As

Publication number Publication date
GB1138405A (en) 1969-01-01
BE708557A (de) 1968-06-27
DE1695295A1 (de) 1975-03-20
NL157303B (nl) 1978-07-17
NL6717719A (de) 1968-07-01
FR1571341A (de) 1969-06-20
FR7557M (de) 1969-12-29
US3714161A (en) 1973-01-30
DE1695295C2 (de) 1984-01-05

Similar Documents

Publication Publication Date Title
CH501647A (de) Verfahren zur Herstellung von Piperazinderivaten
CH492676A (de) Verfahren zur Herstellung von 1-Phenyl-2-aminoäthanol-Derivaten
CH504452A (de) Verfahren zur Herstellung von Morpholinderivaten
CH491119A (de) Verfahren zur Herstellung von N6-Aralkyl-adenosin-derivaten
CH489517A (de) Verfahren zur Herstellung von N-Acylsydnoniminderivaten
CH460020A (de) Verfahren zur Herstellung von Piperazinderivaten
CH513911A (de) Verfahren zur Herstellung von Piperazinderivaten
CH478133A (de) Verfahren zur Herstellung von Isothiazol-Derivaten
CH494206A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH493465A (de) Verfahren zur Herstellung von Alkanolaminderivaten
CH461461A (de) Verfahren zur Herstellung von Derivaten des N-Acylvinylamins
CH510640A (de) Verfahren zur Herstellung von Diarylcyclopropan-Derivaten
CH485763A (de) Verfahren zur Herstellung von Dibenzothiazinderivaten
CH496005A (de) Verfahren zur Herstellung von Piperazin-Derivaten
CH457452A (de) Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten
CH489509A (de) Verfahren zur Herstellung von Derivaten des Piperazins
CH458362A (de) Verfahren zur Herstellung von Piperazinderivaten
CH481901A (de) Verfahren zur Herstellung von 16-Methylen-19-norprogesteron-derivaten
CH521358A (de) Verfahren zur Herstellung von Phenazinderivaten
CH496663A (de) Verfahren zur Herstellung von 2-Benzyliden-cyclopentanonderivaten
CH471146A (de) Verfahren zur Herstellung von neuen Morpholinderivaten
CH458370A (de) Verfahren zur Herstellung von Imidazolidinonsulfonamidderivaten
CH497411A (de) Verfahren zur Herstellung von neuen Homogonan-Derivaten
CH488720A (de) Verfahren zur Herstellung von Isothiazolderivaten
CH471831A (de) Verfahren zur Herstellung von 1-Hydroxy-östradiol-Derivaten

Legal Events

Date Code Title Description
PL Patent ceased